GH Research (GHRS) Other Accumulated Expenses (2021 - 2025)

GH Research's (GHRS) quarterly Other Accumulated Expenses came in at $4.2 million in Q4 2025, down 14.42% year-on-year from $5.0 million in Q4 2024, and down 31.65% quarter-over-quarter from $6.2 million in Q3 2025.

GH Research (GHRS) Other Accumulated Expenses (2021 - 2025) Analysis & Trends

GH Research's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $4.2 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 14.42% year-over-year to $4.2 million in Q4 2025; TTM through Dec 2025 was $4.2 million, a 14.42% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, down 14.42% from the prior year.
  • Other Accumulated Expenses eased to $4.2 million in Q4 2025 per GHRS's latest filing, from $6.2 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $6.6 million in Q3 2024 and bottomed at $819000.0 in Q3 2021.
  • The 5-year median for Other Accumulated Expenses is $3.4 million (2023), against an average of $3.7 million.
  • Across the five-year window, Other Accumulated Expenses surged 143.37% in 2023 and dropped 14.42% in 2025, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $3.0 million in 2021, then fell by 10.22% to $2.7 million in 2022, then advanced by 7.09% to $2.9 million in 2023, then jumped by 72.84% to $5.0 million in 2024, then declined by 14.42% to $4.2 million in 2025.
  • Per Business Quant, the three latest GHRS Other Accumulated Expenses figures stand at $4.2 million (Q4 2025), $6.2 million (Q3 2025), and $6.2 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.67 Bn 466.88 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.32 Bn 115.07 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn
7 Belite Bio 62.06 Bn 62.06 Bn -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.55 Bn 34.54 Bn 959.66 Mn
10 GH Research 1.72 Bn 1.48 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.24 Mn
Sep 30, 2025 6.21 Mn
Jun 30, 2025 6.16 Mn
Mar 31, 2025 4.81 Mn
Dec 31, 2024 4.96 Mn
Sep 30, 2024 6.57 Mn
Jun 30, 2024 4.97 Mn
Mar 31, 2024 3.39 Mn
Dec 31, 2023 2.87 Mn
Sep 30, 2023 3.17 Mn
Jun 30, 2023 3.38 Mn
Mar 31, 2023 3.38 Mn
Dec 31, 2022 2.68 Mn
Sep 30, 2022 1.64 Mn
Jun 30, 2022 1.39 Mn
Mar 31, 2022 2.52 Mn
Dec 31, 2021 2.98 Mn
Sep 30, 2021 819,000.00